Creatinine and eGFR (Estimated Glomerular Filtration Rate)
Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.
Number of studies
2
Safety
Requires caution
Time to effects
Not applicable — the creatinine and eGFR test is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.
- →Detects reduced kidney function at an early, asymptomatic stage, when intervention is most effective
- →eGFR enables staging of chronic kidney disease and dose adjustment for kidney-cleared medications
- →Regular monitoring distinguishes stable, chronic kidney function from an acute decline requiring urgent workup
| Test type | A blood test — creatinine level converted to eGFR using the CKD-EPI equation |
|---|---|
| Level of evidence | Strong — the CKD-EPI equation is the recommended standard for estimating glomerular filtration |
| Target group | Any adult as part of prevention, especially those with diabetes, hypertension, or on nephrotoxic medications |
| Key parameters | Serum creatinine, eGFR (mL/min/1.73m²), chronic kidney disease stage per KDIGO (G1–G5) |
| Preparation | Usually doesn't require fasting; avoiding intense exertion and a large meat-heavy meal the day before is advised |
| Status | A standard screening and monitoring test for kidney function |
Understand
Overview
Creatinine is a byproduct of muscle phosphocreatine breakdown, excreted mainly by the kidneys through glomerular filtration. Its blood level depends not only on kidney function but also on muscle mass, age, sex, and diet, so a single, isolated creatinine value can be misleading — someone with low muscle mass can have a seemingly normal creatinine despite significantly reduced kidney function.
eGFR (estimated Glomerular Filtration Rate) converts creatinine, age, and sex into an approximate filtration rate in milliliters per minute per 1.73 square meters of body surface area, using the CKD-EPI equation developed by the Chronic Kidney Disease Epidemiology Collaboration. It's eGFR, not creatinine alone, that forms the basis for classifying chronic kidney disease into stages G1 through G5 under the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines.
The CKD-EPI equation itself has been revised since its original 2009 publication. A 2021 study led by Inker and colleagues, published in the New England Journal of Medicine, developed new creatinine-based and combined creatinine-cystatin C-based equations that remove the race coefficient present in the original formula, after that coefficient was found to produce systematically different eGFR estimates — and therefore different access to kidney-related care and transplant eligibility — for Black versus non-Black patients at the same true filtration rate. The National Kidney Foundation and American Society of Nephrology task force now recommends the race-free 2021 CKD-EPI creatinine equation for routine use, and specifically recommends broader use of cystatin C — a protein produced by essentially all nucleated cells at a fairly constant rate, largely independent of muscle mass — in combination with creatinine, since the combined equation was shown to be more accurate against measured GFR and produced smaller differences in estimated kidney function between population groups than either marker alone. In practice, this means a creatinine-only eGFR can still be meaningfully off in a patient whose muscle mass is far from average, and adding a cystatin C-based calculation is the recommended way to resolve that uncertainty, rather than relying on creatinine alone.
Who can genuinely benefit from this? Any adult as part of routine prevention, and especially people with diabetes, hypertension, obesity, or a family history of kidney disease, as well as patients on nephrotoxic medications or drugs cleared mainly by the kidneys that need dose adjustment. A single abnormal eGFR result usually needs to be confirmed on a repeat test at least three months later, to distinguish chronic kidney function decline from a transient, acute injury.
Mechanism of action
Creatinine forms from the spontaneous, nonenzymatic breakdown of phosphocreatine in skeletal muscle, at a rate roughly proportional to total muscle mass, and is then cleared from the blood mainly through glomerular filtration, with a small additional contribution from active tubular secretion. This means its blood level rises both when glomerular filtration genuinely declines and when muscle mass increases, independent of kidney status — which is why interpreting creatinine alone, without accounting for a person's age, sex, and body composition, is unreliable.
The CKD-EPI equation adjusts creatinine for age and sex to estimate true glomerular filtration — a validation study of nearly 4,000 participants showed it to be more accurate than the previously widely used MDRD equation, especially at higher filtration values. Because the relationship between creatinine and eGFR is not linear but inverse and curvilinear, even a small, seemingly minor rise in creatinine at an already reduced kidney function corresponds to a much larger, proportionally greater drop in eGFR.
Creatinine formation in muscle
Spontaneous breakdown of phosphocreatine in skeletal muscle generates creatinine at a rate roughly proportional to muscle mass.
Glomerular filtration and minor tubular secretion
Creatinine is cleared mainly through glomerular filtration, with a small contribution from tubular secretion that can overestimate eGFR in advanced kidney failure.
Conversion to eGFR via the CKD-EPI equation
Creatinine is adjusted for age and sex to estimate glomerular filtration and assign a chronic kidney disease stage per the KDIGO classification.
Evidence: strong — based on 2 studies in this database.
Benefits
Common myths
MythNormal creatinine always means healthy kidneys.
FactCreatinine can stay within the reference range despite significant kidney function loss in people with low muscle mass, such as older or debilitated patients — what matters is the calculated eGFR, not the creatinine value alone.
MythOne abnormal eGFR result means chronic kidney disease.
FactDiagnosing chronic kidney disease requires confirming a reduced eGFR or other abnormalities on a repeat test at least three months later — a single result may reflect a transient, acute decline.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
It's not required, though avoiding a very large meat-heavy meal and intense physical exertion right before the blood draw is advised, since they can temporarily raise the result.
eGFR is a value estimated from a mathematical equation using creatinine, age, and sex, while creatinine clearance is a direct measurement requiring a 24-hour urine collection — in clinical practice, eGFR is sufficient in the vast majority of cases.
An eGFR below 15 mL/min/1.73m² corresponds to stage G5, or end-stage kidney failure, under the KDIGO classification, but values below 60 mL/min/1.73m² persisting for more than three months already qualify as chronic kidney disease requiring further care.
Cystatin C is a protein produced at a fairly constant rate by nearly all nucleated cells, largely independent of muscle mass, which makes it a useful complement to creatinine in people whose muscle mass is unusually low or high — such as older or debilitated patients, amputees, or heavily muscled athletes — where creatinine alone can give a misleading eGFR. A 2021 equation combining creatinine and cystatin C, now recommended by the National Kidney Foundation and American Society of Nephrology, is more accurate against directly measured GFR than either marker used alone.
What to combine with
Good combinations
Electrolytes: Sodium, Potassium, and Chloride — Declining kidney function is often accompanied by electrolyte disturbances, especially elevated potassium — it's worth interpreting both results together
Hypertension — Hypertension is both a cause and a consequence of chronic kidney disease, so it's worth monitoring both parameters in parallel
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
A high-protein meal, especially red meat, eaten before the test can temporarily raise creatinine
Intense physical exertion and dehydration can falsely raise creatinine independent of actual kidney function
Certain medications, e.g., trimethoprim or cimetidine, block tubular creatinine secretion and raise its level without a real drop in glomerular filtration
Very low or very high muscle mass, e.g., with sarcopenia or intensive strength training, distorts the interpretation of creatinine alone without reference to eGFR
Is it worth taking?
Who it's for
- Any adult as part of routine prevention, especially after age 40
- People with diabetes, hypertension, or on nephrotoxic medications
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
An eGFR below 60 mL/min/1.73m² persisting for more than three months is one of the criteria for diagnosing chronic kidney disease under the KDIGO guidelines.
The relationship between creatinine and eGFR is inverse and nonlinear — at an already reduced kidney function, even a small rise in creatinine corresponds to a large drop in filtration.
A 2021 revision of the CKD-EPI equation removed its race coefficient and added a version combining creatinine with cystatin C, which the National Kidney Foundation/American Society of Nephrology task force now recommends for more accurate, more equitable eGFR estimates.
Studies
The CKD-EPI equation performed better than the previously used MDRD equation, especially at higher glomerular filtration values, and could replace it for routine clinical use.
Levey AS, Stevens LA, Schmid CH, et al. (CKD-EPI), Annals of Internal Medicine, 2009
A New Equation to Estimate Glomerular Filtration Rate
Strong evidenceLevey AS, Stevens LA, Schmid CH, et al. · Annals of Internal Medicine · 2009
A validation study of the CKD-EPI equation in nearly 4,000 participants, showing greater accuracy than the older MDRD equation, especially at higher glomerular filtration values.
View studyEvaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline
Strong evidenceStevens PE, Levin A, for the KDIGO CKD Guideline Development Work Group Members · Annals of Internal Medicine · 2013
A synopsis of the KDIGO guideline defining chronic kidney disease staging based on eGFR and the principles of monitoring and further workup.
View studySources & bibliography
- Levey et al. 2009 — Annals of Internal Medicine
- Stevens, Levin 2013 — KDIGO Synopsis, Annals of Internal Medicine
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
Redakcja VitMode — Hormony i endokrynologiaEditorial team
VitMode Editorial — Hormones and Endocrinology is the VitMode editorial team responsible for: hormones, testosterone therapy, the thyroid and metabolism. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
328 publications on this site
Editorial review
Redakcja VitMode — Serce i układ krążeniaEditorial team
VitMode Editorial — Heart and Circulation is the VitMode editorial team responsible for: the heart, blood pressure, lipids and cardiovascular prevention. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
75 publications on this site
Related entries
How to Read a Basic Blood Test Panel
CBC, lipid panel, glucose, TSH — how to read the results of a basic blood panel so you catch early signals of a problem before it becomes a disease.
Electrolytes: Sodium, Potassium, and Chloride
Sodium, potassium, and chloride sound like a chemistry-class topic, but their blood levels determine how your heart, muscles, and kidneys function — and even a small deviation can be an urgent warning sign.
Hypertension
The 'silent killer' — it runs symptom-free for years, yet it's one of the strongest, and largely modifiable, risk factors for stroke and heart attack in the world.
Complete Blood Count (CBC)
The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.
Liver Panel (ALT, AST, GGT, Bilirubin)
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
Uric Acid (Blood Test)
Uric acid is the end product of purine breakdown — its blood test helps assess the risk of gout and kidney stones, but a single result on its own neither confirms nor rules out disease.
Total Protein and Albumin Blood Test
Total protein and albumin are among the oldest, yet also most ambiguous, laboratory panels — the same low result can mean malnutrition, kidney disease, chronic inflammation, or simply blood dilution from IV fluids, and telling these scenarios apart takes more than a single number on a printout.
Chronic Kidney Disease (CKD)
A progressive, usually symptomless loss of kidney function affecting up to one in nine adults worldwide — and a condition in which even a small drop in glomerular filtration is linked, in large cohort studies, to a significantly higher risk of cardiovascular death.
Related articles
PoradnikiCan Dehydration Raise Creatinine Even With Healthy Kidneys?
Dehydration can transiently raise a creatinine result even in someone with healthy kidneys — through two overlapping mechanisms: blood concentration and reduced kidney blood flow. We explain when this actually matters and when it doesn't.
September 27, 2026
PoradnikiCan Eating Meat Before a Test Raise Creatinine?
A large cooked-meat meal can raise blood creatinine much more than most people expect — a classic study found an increase of nearly half. We explain the mechanism and how many hours you should wait before a test.
September 27, 2026
PoradnikiDo You Need to Stop Creatine Before a Creatinine Test?
Usually you don't need to stop creatine before a routine blood test. We explain when a break actually makes sense, how long it should last, and why skipping one day barely changes anything.
September 27, 2026
PoradnikiCan Creatine Raise Creatinine Even With Healthy Kidneys?
Creatine supplementation almost always raises your blood creatinine result — that's a fact confirmed across dozens of studies. The question is whether that means a kidney problem or just an artifact of how eGFR is calculated. We answer directly and show how much the result really rises.
September 27, 2026
PoradnikiIbuprofen and Alcohol: Can You Mix Them and What Is the Risk?
Ibuprofen and alcohol do not trigger a dangerous chemical reaction, but both irritate the stomach lining and both can burden the kidneys. The best available data come from a case-control study of 1,224 people with upper gastrointestinal bleeding: regular ibuprofen use was linked to a risk about 2.7 times higher, while occasional use showed no significant increase. We explain what this means for someone who fancies a glass of wine and a tablet for a headache, who should avoid the combination altogether, and what science does not yet know.
November 3, 2026
PoradnikiNSAIDs, Blood Pressure and the Kidneys: Who Should Be Careful
Nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen, diclofenac) can raise blood pressure by about 5 mmHg on average and weaken blood pressure medicines, and combined with a diuretic and an ACE inhibitor or sartan they form the so-called triple whammy for the kidneys. We present data from a meta-analysis of randomised trials, from a 4-month trial with ambulatory blood pressure monitoring, from a large population study and from a Cochrane review of drugs applied to the skin. We also explain why paracetamol is not entirely neutral for blood pressure either, who should be most careful and what to do instead of reaching for a tablet.
November 3, 2026
PoradnikiMRI Scan: Claustrophobia, Gadolinium Contrast and Implants
An MRI scan raises three common worries: the narrow tube, gadolinium contrast and metal in the body, such as a pacemaker, joint replacements or tattoos. We explain what is actually known: how often the scan is interrupted by anxiety and what helps (a randomised trial from 2026), what the risk of nephrogenic systemic fibrosis (NSF) looks like with newer contrast agents, what gadolinium deposition in tissues means, when a pacemaker is not an obstacle and what to tell the staff before the scan. We also note where the evidence is weak or applies only to some groups.
November 3, 2026
PoradnikiCT Scan with Contrast: Kidneys, Metformin and Allergy — What Is Really Known
Iodinated contrast in computed tomography is tied to three common worries: that it will damage the kidneys, that metformin must be stopped, and that an allergy to iodine or seafood rules out the scan. Current data are calmer than tradition suggests: in a meta-analysis of 28 studies (107,335 people) contrast CT was not significantly associated with acute kidney injury, the randomised AMACING trial showed no benefit of routine hydration at eGFR 30–59, and an 'iodine allergy' in the sense of an ordinary allergen does not exist. We explain who still needs caution and what information the patient should pass on.
November 3, 2026